Featured Research

from universities, journals, and other organizations

Gene Directs Stem Cells To Build The Heart

Date:
July 3, 2008
Source:
Washington University School of Medicine
Summary:
Researchers have shown that they can put mouse embryonic stem cells to work building the heart, potentially moving medicine a significant step closer to a new generation of heart disease treatments that use human stem cells. Scientists report in Cell Stem Cell that the Mesp1 gene locks mouse embryonic stem cells into becoming heart parts and gets them moving to the area where the heart forms.

Researchers have shown that they can put mouse embryonic stem cells to work building the heart, potentially moving medical science a significant step closer to a new generation of heart disease treatments that use human stem cells.

Related Articles


Scientists at Washington University School of Medicine in St. Louis report in Cell Stem Cell that the Mesp1 gene locks mouse embryonic stem cells into becoming heart parts and gets them moving to the area where the heart forms. Researchers are now testing if stem cells exposed to Mesp1 can help fix damaged mouse hearts.

"This isn't the only gene we'll need to get stem cells to repair damaged hearts, but it's a key piece of the puzzle," says senior author Kenneth Murphy, M.D., Ph.D., professor of pathology and immunology and a Howard Hughes Medical Institute investigator. "This gene is like the first domino in a chain: the Mesp1 protein activates genes that make other important proteins, and these in turn activate other genes and so on. The end result of these falling genetic dominoes is your whole cardiovascular system."

Embryonic stem cells have created considerable excitement because of their potential to become almost any specialized cell type. Scientists hope to use stem cells to create new tissue for treatment of a wide range of diseases and injuries. But first they have to learn how to coax them into becoming specialized tissue types such as nerve cells, skin cells or heart cells.

"That's the challenge to realizing the potential of stem cells," says Murphy. "We know some things about how the early embryo develops, but we need to learn a great deal more about how factors like Mesp1 control the roles that stem cells assume."

Mesp1 was identified several years ago by other researchers, who found that it was essential for the development of the cardiovascular system but did not describe how the gene works in embryonic stem cells.

Using mouse embryonic stem cells, Murphy's lab showed that Mesp1 starts the development of the cardiovascular system. They learned the gene's protein helps generate an embryonic cell layer known as the mesoderm, from which the heart, blood and other tissues develop. In addition, Mesp1 triggers the creation of a type of cell embryologists recently recognized as the heart's precursor.

They also found that stem cells exposed to the Mesp1 protein are locked into becoming one of three cardiovascular cell types: endothelial cells, which line the interior of blood vessels; smooth muscle cells, which are part of the walls of arteries and veins; or cardiac cells, which make up the heart.

"After they are exposed to Mesp1, the stem cells don't make any decisions for several days as to which of the three cell types they're going to become," Murphy notes. "The cues that cause them to make those commitments come later, in the form of proteins from other genes."

Researchers already know a number of the genes that shape the heart later in its development. Murphy plans to start tracing Mesp1's effects from gene to gene--following the falling genetic dominoes, which branch out into the pathways that form the three cardiac cell types.

"If we can find gene combinations that only make endothelium or cardiac or smooth muscle, then that could be applied to tailoring embryonic stem cells for therapies later on," he says.


Story Source:

The above story is based on materials provided by Washington University School of Medicine. Note: Materials may be edited for content and length.


Journal Reference:

  1. Lindsley RC, Gill JG, Murphy TL, Langer EM, Cai M, Mashayekhi M, Wang W, Niwa N, Nerbonne JM, Kyba M and Murphy KM. Mesp1 coordinately regulates cardiovascular fate restriction and epithelial-mesenchymal transition in differentiating ES cells. Cell Stem Cell, July 3, 2008

Cite This Page:

Washington University School of Medicine. "Gene Directs Stem Cells To Build The Heart." ScienceDaily. ScienceDaily, 3 July 2008. <www.sciencedaily.com/releases/2008/07/080702121143.htm>.
Washington University School of Medicine. (2008, July 3). Gene Directs Stem Cells To Build The Heart. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2008/07/080702121143.htm
Washington University School of Medicine. "Gene Directs Stem Cells To Build The Heart." ScienceDaily. www.sciencedaily.com/releases/2008/07/080702121143.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) — The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins